Concepedia

Prevalence and risk factors for developing K65R mutations among HIV-1 infected patients who fail an initial regimen of fixed-dose combination of stavudine, lamivudine, and nevirapine

Somnuek Sungkanuparph, Weerawat Manosuthi, Sasisopin Kiertiburanakul, Nipa Saekang, Wantanit Pairoj, Wasun Chantratita

Journal of Clinical Virology · 2008 · 31 citations · 16 references

References

16

UPDATE ON DRUG RESISTANCE MUTATIONS IN HIV-1

&NA; · Infectious Diseases in Clinical Practice · 2001 · 1.7K citations

Life Sciences, Genetics, Molecular Genetics +17

Efficacy and Safety of Tenofovir DF vs Stavudine in Combination Therapy in Antiretroviral-Naive Patients<SUBTITLE>A 3-Year Randomized Trial</SUBTITLE>

Joel E. Gallant · JAMA · 2004 · 1.3K citations

Pharmacy, Pharmacology, Pharmacotherapy +17

A Randomized, Double-blind Trial Comparing Combinations of Nevirapine, Didanosine, and Zidovudine for HIV-Infected Patients

Julio Montaner, David A. Cooper, Stefano Vella et al. · JAMA · 1998 · 772 citations

Pharmacy, Pharmacotherapy, Clinical Pharmacology +16

Update of the drug resistance mutations in HIV-1: Fall 2005.

Victoria A. Johnson, Françoise Brun‐Vézinet, Bonaventura Clotet et al. · PubMed · 2006 · 263 citations

Life Sciences, Pharmacology, Molecular Epidemiology +16

Survival Rate and Risk Factors of Mortality Among HIV/Tuberculosis-Coinfected Patients With and Without Antiretroviral Therapy

Weerawat Manosuthi, Suthat Chottanapand, Supeda Thongyen et al. · JAIDS Journal of Acquired Immune Deficiency Syndromes · 2006 · 259 citations

Public Health, Infectious Diseases, Clinical Epidemiology +15